MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
CMND — Clearmind Medicine Inc. Common Shares
NasdaqClearmind Medicine Inc. Common Shares
$0.72
-0.00(-0.11%)
- O
- 0.74
- H
- 0.74
- L
- 0.71
- V
- 95.26K
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About CMND
Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.
IndustryCommon Stock
SectorNot available
IPO DateAug 10, 2021
Employees2
Stock ExchangeNasdaq
Ticker SymbolCMND
Key Financial Statistics
| Market Cap | $2.70M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $0.71 - $480.00 |
| 52-Week Avg Volume | 735.1K |
| VWAP | $0.72 |
| Transactions | 6,636 |
| Total Recorded Bars | 973 days |